Chasing Compliance: The Global Regulatory Podcast

13

November 08, 2021 • 00:34:28

Part 1 - Abbreviated New Drug Applications: Fundamentals, Challenges, and Agency Communication

Chasing Compliance: The Global Regulatory Podcast kicks off season two with a two-part episode on abbreviated new drugs applications (ANDAs). Our guest today, Sandra...

12

July 15, 2021 • 00:24:29

Part 2 - Clinical Site Selection and Evaluation: Tips and Best Practices

Welcome to clinical site selection and evaluation Part 2, where we continue the conversation on optimizing clinical site selection and evaluation. In this episode...

11

June 15, 2021 • 00:37:02

Part 1 - Clinical Site Selection and Evaluation: Acceleration Through Effective Collaboration

This is part 1 on our conversation on optimizing clinical site selection and evaluation. In this episode Linda Peterson and Julie Sheidy provide some...

10

May 11, 2021 • 00:33:30

Part 3 - Graduates of the The Global CER Internship Program Share Their Stories

This episode of Chasing Compliance features two first-hand accounts of what it was like to participate in the Global Clinical Evaluation Report (CER) Internship...

9

April 13, 2021 • 00:26:33

Introducing The Global Regulatory Writing and Consulting Blog

We are excited to announce the launch of the official Global Regulatory and Consulting Blog. To celebrate the release of the first blog posts...

8

March 26, 2021 • 00:48:02

Generic Pharmaceuticals: Development, Testing, and Regulation

In this episode of Chasing Compliance, Jamie talks with Brandi Quinlin and Rebecca Lynch about generic drugs. The discussion ranges from what a generic...